Liver Cancer
CD44v3 predicts the risk of hepatocellular carcinoma distant metastasis
Published in Hepatitis Weekly, November 1st, 2004
According to published research from Japan, "numbers of patients with extrahepatic metastasis of hepatocellular carcinoma (HCC) are increasing. As characteristics of HCC patients who develop distant metastasis remain uncertain, we analyzed potential risk factors."
"Among patients followed up after hepatic resection for HCC, we identified 31 patients with extrahepatic metastasis (extrahepatic metastasis group, EM). In 46 other patients we found intrahepatic metastasis synchronously with the primary HCC. In these patients no extrahepatic metastasis occurred during 5 years of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-11-01)
More Articles from Hepatitis Weekly
- Cancer Risk Factor
Hepatitis B virus core promoter mutations prevail in liver cancer - Chronic Hepatitis B
Lamivudine does not improve the response of hepatitis B to peginterferon - Diagnostics
Total HCV core antigen assay detects early infection but not viral elimination - Hematology
A new magnetic extraction method uncovers HCV status in hemodialysis patients - Liver Cancer
Patients with hepatic fibrosis and hepatitis C need broader cancer screenings - Adverse Drug Effects
Combination therapy for liver cancer is linked to interstitial pneumonia - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
